Atezolizumab,Cabozantinib
Roche
['cabo ', 'atezo']
another practice-changing trial presented today by #asco23 no benefit of adding atezo to cabo after progression on io! huge implications for our patients in terms of reducing financial #toxicity and iraes 
Postdoctoral GU Oncology Research Fellow @DanaFarber
MD '22 MSc '21 @USJLiban